Federal Contract Awarded to Case Western for Live Joint Development
Mirage News,
Goal is life-changing treatment for osteoarthritis-most common degenerative joint disease affecting 500 million people…
Goal is life-changing treatment for osteoarthritis-most common degenerative joint disease affecting 500 million people…
Goal is life-changing treatment for osteoarthritis—most common degenerative joint disease affecting 500 million people…
Post Views: 3 CLEVELANDAbout 32.5 million people in the United States and 500 million globally suffer from the degenerative…
CLEVELAND—About 32.5 million people in the United States and 500 million globally suffer from the degenerative joint disease…
Obesity and diabetes increase the risk for complications following joint surgeries like total hip replacement, but can…
Obesity and diabetes increase the risk for complications following joint surgeries like total hip replacement, but can…
Adults with osteoarthritis who took part in a digital musculoskeletal program had lower rates of knee and hip arthroplasty at…
ABSTRACT Objectives: To evaluate opportunity gaps and set outcome goals in knee replacement (KR) between a primary care group…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
2022-09-07 NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions…
News provided by AposHealth Sep 07, 2022, 2:20 PM ET NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
Please enter a search term. Please enter a search term. News provided by Sep 07, 2022, 2:20 PM ET NEW YORK, Sept.
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 -- A recent study on Apos®, a medical device that treats chronic knee conditions, could have…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
Apos®, a Non-Invasive Knee Treatment, Proven to Delay Surgery According to a Real-World Study PR Newswire NEW YORK, Sept.
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
, - A recent study on Apos®, a medical device that treats chronic knee conditions, could have significant implications on the…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
Published: Sep. 7, 2022 at 1:20 PM CDT|Updated: 11 minutes ago NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ A recent study on Apos®, a medical device that treats chronic knee conditions, could have…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
, - A recent study on Apos®, a medical device that treats chronic knee conditions, could have significant implications on the…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 -- A recent study on Apos®, a medical device that treats chronic knee conditions, could have…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
Published: Sep. 7, 2022 at 1:20 PM CDT|Updated: 7 minutes ago NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
Published: Sep. 7, 2022 at 1:20 PM CDT|Updated: 6 minutes ago NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®…
NEW YORK, Sept. 7, 2022 /PRNewswire/ -- A recent study on Apos®, a medical device that treats chronic knee conditions, could…
– Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics – Nicholas Pachuda, DPM, promoted to Chief…
PITTSBURGH--(BUSINESS WIRE)-- Peptilogics, a clinical stage biotech company engineering peptide therapeutic solutions for…
- Peptilogics, a clinical stage biotech company engineering peptide therapeutic solutions for patients with life-threatening…
– Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics – Nicholas Pachuda, DPM, promoted to Chief…
– Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics – Nicholas Pachuda, DPM, promoted to Chief…
Aug. 10, 2022 12:30 UTC – Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics – Nicholas Pachuda…
– Atul Deshpande, Ph.D., MBA, A-PMP, appointed Chief Strategy Officer at Peptilogics – Nicholas Pachuda, DPM, promoted to Chief…
Did you know that your grandma could become addicted to opioids because of a knee replacement? It’s more likely than you might…
Orthopedic and spine surgery volume is recovering from the early days of the COVID-19 pandemic, and first-quarter medtech…
April 6 (UPI) -- A steroid injection provides "significantly" more pain relief for people with hip osteoarthritis than other…
A steroid injection may help reduce pain for people with hip osteoarthritis, according to a new study.
The American Academy of Orthopedic Surgeons estimates that each year, more than 450,000 Americans have their hips replaced—more…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Author: Publish date: WAUKESHA…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
Kinex Medical Releases Pivotal Market Report on the Future of Telerehabilitation 87% of orthopedic surgeons believe…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ --, a leading provider of orthopedic specialty medical equipment for acute, post-acute…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
WAUKESHA, Wis., Jan. 20, 2022 /PRNewswire/ -- Kinex Medical, a leading provider of orthopedic specialty medical equipment for…
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery Published: Jan.
87% of orthopedic surgeons believe telerehabilitation is the future of post-operative recovery WAUKESHA, Wis., Jan.